Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 185, Issue 8, 2002, Pages 1103-1114

  De Repentigny, Louis ^a,b   Aumont, Francine ^a   Ripeau, Jean Sébastien ^a   Fiorillo, Marie ^a   Kay, Denis G ^c   Hanna, Zaher ^a,c   Jolicoeur, Paul ^a,c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AIDS RELATED COMPLEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BODY BURDEN; CANDIDA ALBICANS; CARDIA; CELL INFILTRATION; CLEARANCE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CARRIER; ESOPHAGUS MUCOSA; FUNGUS HYPHAE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH EPITHELIUM; STRAIN DIFFERENCE; THRUSH; TRANSGENIC MOUSE;

ANIMALS; CANDIDIASIS, ORAL; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C3H; MICE, TRANSGENIC;

EID: 0037090333     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340036     Document Type: Article

References (75)

1. Oral candidiasis and human immunodeficiency virus infection
2. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients
3. Classification and diagnostic criteria for oral lesions in HIV infection
4. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome
5. Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients
6. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: Evidence for two patterns of recurrence
7. Infection due to fluconazole-resistant Candida in patients with AIDS prevalence and microbiology
8. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection
9. Immunologic aspects of oral candidiasis
10. Oral keratinocyte immune responses in HIV-associated candidiasis
11. Pseudomembranous oral candidiasis in HIV infection: Ultrastructural findings
12. Immunocompetent cells in oral candidiasis of HIV-infected patients: An immunohistochemical and electron microscopical study
13. Macrophages in resistance to candidiasis
14. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons
15. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus
16. The leucocyte protein L1 (calprotectin) a putative nonspecific defence factor at epithelial surfaces
17. Nef harbours a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in Tg mice
18. Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice
19. Jolicoeur P Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease
20. Comparison of methods for the evaluation of the oral microbiota of mice
21. Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter
22. Oral carriage of Candida albicans in murine AIDS
23. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ, and HLADP
24. A comparative study on tissue processing procedures for the immunohistochemical investigation of oral mucosal Langerhans cells
25. Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin
26. High levels of oral yeasts in early HIV-1 infection
27. Oral defense mechanisms are impaired early in HIV-1 infected patients
28. Asymptomatic oral carriage of Candida albicans in patients with HIV infection
29. Candidemia in HIV-infected subjects
30. Epidemiological and clinical aspects of mycoses in patients with AIDS-related pathologies
31. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance
32. + lymphocytes in resistance to mucosal candidiasis
33. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice
34. Mucosal and systemic candidiasis in congenitally immunodeficient mice
35. Mucosal and disseminated candidiasis in gnotobiotic SCID mice
36. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: Role of polymorphonuclear leukocytes and macrophages
37. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice
38. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome
39. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development
40. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis
41. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats
42. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody
43. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans
44. Oral immunization of mice against candidiasis
45. + T cells during experimented oral candidiasis in anti-CD4-treated mice
46. -/-) mice
47. Oral candidiasis in HIV infection: Pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS
48. Impaired dendritic cell function in HIV-1 transgenic murine model
49. Antigen presenting capacity of Langerhans cells from rat oral epithelium
50. Purified human oral mucosal Langerhans cells function as accessory cells in vitro
51. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection
52. + subjects
53. Oral mucosal Langerhans' cells
54. Langerhans cells: Structure, function and role in oral pathological conditions
55. Mucosal dendritic cells and immunodeficiency viruses
56. Epidermal and mucosal dendritic cells and HIV1 infection
57. Langerhans cells and HIV infection
58. Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients
59. HIV-infected Langerhans cells constitute a significant proportion of the epidermal Langerhans cell population throughout the course of HIV disease
60. HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo
61. Reduced number of Langerhans cells in oral mucosal washings from HIV-1 seropositives
62. Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients
63. Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection
64. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
65. + T-cells by HIV-infected monocytes is related to down-modulation of CD4 expression on helper T-cells: Possible involvement of HIV-induced cellular factors
66. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons
67. Dendritic cells and the control of immunity
68. Enhancement of MHC class II antigen expression by exposure to Candida albicans
69. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
70. The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-γ and IL-6
71. Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and -DR
72. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR
73. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation